Quarterly report · Q1
4626.TEDINET S100OSAU
Period2022-04-01 → 2022-06-30
Filed2022-07-27
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.8bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.6bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥4.3bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.5bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.5bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.6bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.1bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.6bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥3.2bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥191.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥189.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥180.9bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥101.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥103.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥89.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥85.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥77.3bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥50.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥51.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥64.47 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.13 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.02 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 46.7% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥859m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥786m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥72m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥7m |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥5.2bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥482m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥25.0bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥25.0bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥25.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥25.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥72m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥5.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥863m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥840m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥23m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥8m |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥16.8bn |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥16.8bn |
| jpcrp040300-q1r_E00913-000Electronics Materialsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥3.8bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥5.9bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥5.9bn |
| jpcrp040300-q1r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥730m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥22.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥22.7bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 348
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | CurrentYTDDuration | 3619000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 74000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -143000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 316000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 2480000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -2000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 390000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 2334000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 3547000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 5954000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 3499000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 5954000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 48000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -0 | JPY |
| Trade notes receivable transferred by endorsement | Prior1YearInstant | 604000000 | JPY |
| Trade notes receivable transferred by endorsement | CurrentQuarterInstant | 679000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 16849000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5879000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 22728000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 840000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 23568000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 23000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 23000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 16849000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5879000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 22728000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 863000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 23591000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 3807000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 730000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 4537000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -8000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4528000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 19293000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5678000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 24971000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 786000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 25757000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 72000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 72000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 19293000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 5678000000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 24971000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |